Alvin Shih - 20 Jan 2024 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role: Director
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Alvin Shih
Issuer symbol: ZVRA
Transactions as of: 20 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 02 Feb 2024, 20:08:38 UTC
Next filing: 15 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZVRA	Stock Option (right to buy)	Award	$0	+58,800		$0.000000	58,800	20 Jan 2024	Common Stock	58,800	$5.72	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, January 19, 2024.
F2	Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 33.33% of the shares will vest on January 20, 2025 and the remaining 66.67% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Content

The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, January 19, 2024.

Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 33.33% of the shares will vest on January 20, 2025 and the remaining 66.67% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.